It is currently Sat Feb 13, 2016 1:01 am

News News of Aubagio (teriflunomide)

Site map of Aubagio (teriflunomide) » Forum : Aubagio (teriflunomide)

Aubagio is an oral treatment approved for MS.

Early Aubagio ‘preferable for preventing disease progression

Early Aubagio ‘preferable for preventing disease progression’

Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more -
Read more : Early Aubagio ‘preferable for preventing disease progression | Views : 637 | Replies : 0

Aubagio ‘slows brain atrophy in RRMS patients’

Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More -
Read more : Aubagio ‘slows brain atrophy in RRMS patients’ | Views : 353 | Replies : 0

Aubagio - Any suggestions to help with stomach issues

Hello. New poster here. My wife is taking Aubagio at the lower dose. She works a pretty busy desk job and she is constantly having to run to the bathroom since starting on Aubagio. She is getting stomach cramps, then the diarrhea. Obviously, that's not working out too well at work, especially if she is in a meeting or something. I see lots of people having the same stomach issues. Has anyone come up with ...
Read more : Aubagio - Any suggestions to help with stomach issues | Views : 671 | Replies : 1

Live Attenuated Vaccinations

I opened my Aubagio pack last week only to find an FYI insert. I found this part particularly interesting - "You should not receive live attenuated vaccine (Vaccine created by reducing virulence of a virus or a bacteria making it harmless, example Mumps, Measles, Rubella vaccine) during treatment with AUBAGIO. Check with your doctor before receiving any vaccination during treatment or after stopping AUBAGIO." In addition to the MMR vaccine, the Typhoid vaccination is a ...
Read more : Live Attenuated Vaccinations | Views : 1024 | Replies : 0

Oral regimen ‘delays onset of MS’

For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More -
Read more : Oral regimen ‘delays onset of MS’ | Views : 884 | Replies : 0

Conerns on Aubagio

Dear Guys, Hope yu are all well.

I have concerns pertaining the Aubagio medicine which am to start taking in few days time.
Is there any precautions that I need to know before starting the medication?
I have been sufferring from MS since 2007 and the last medication,Gelina,did not give any good results at all.

Please communicate and give my yur views.

Thank you all, waiting for yur replies.
Read more : Conerns on Aubagio | Views : 1960 | Replies : 6

Does everyone experience hairloss in Aubagio?

I've been recently diagnosed with rrms and the doctors have prescribed me Aubagio.

Does everyone on this treatment experience hairloss? I'm a 39 year old male and pretty darn proud to have retained a youthful appearance and full head of hair. Thanks for the advise.
Read more : Does everyone experience hairloss in Aubagio? | Views : 1248 | Replies : 4

FDA approves label change for oral MS drug Aubagio

The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label.

The new labeling content is efficacy and safety data from two Phase III trials of the drug. One trial, a study known as TOPIC is described in the Sept., 2014 issue of The Lancet Neurology. In it Aaron Miller, MD and colleagues report that in 618 relapsing-remitting multiple sclerosis patients assigned ...
Read more : FDA approves label change for oral MS drug Aubagio | Views : 1105 | Replies : 0

Increased skin sensitivity

I've been taking Aubagio 14mg for 7 days. For the first 5 days I felt like I had a bad dose of flu, also queasiness, this has eased off now. The one thing that is persistent and not getting any better is the increased sensitivity in the skin and muscle pain in the tops of my legs, sitting and walking is painful, having any fabric next to legs is uncomfortable. Anyone else experienced this or ...
Read more : Increased skin sensitivity | Views : 1012 | Replies : 0

Early treatment with Teriflunomide may slow MS development

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.

Miller AE, Wolinsky JS, Kappos L, Comi G, Freedman MS, Olsson TP, Bauer D, Benamor M, Truffinet P, O'Connor PW; TOPIC Study Group.


BACKGROUND: Teriflunomide is a once-daily oral immunomodulator approved for the treatment of relapsing-remitting multiple sclerosis. We aimed to assess the efficacy and safety of teriflunomide in patients with a first ...
Read more : Early treatment with Teriflunomide may slow MS development | Views : 724 | Replies : 0


Login  •  Register


Total posts 230446 • Total topics 24479 • Total members 15708

Contact us | Terms of Service